MMLV Reverse Transcriptase Mutants for Structured RNA cDNA Synthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing MMLV and AMV reverse transcriptase enzymes face limitations in thermostability and RNase H activity, leading to reduced efficiency and fidelity in synthesizing long cDNA, particularly with RNA molecules having strong secondary structures.
Innovation Solution
Development of MMLV reverse transcriptase mutants with specific amino acid substitutions, such as Q68R, Q79R, L82Y, L99R, L280I, E282D, T306K, V433N, V433R, I593E, and I593W, enhancing thermostability and reducing RNase H activity, thereby improving cDNA synthesis efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If MMLV RTase is used at elevated temperatures to resolve strong secondary structures, then the ability to reverse transcribe structured RNAs improves, but cDNA length and yield decrease due to lower enzyme activity
Solution Approach 1:
The patent applies parameter changes by introducing specific amino acid substitutions (Q68R, Q79R, L82Y, L99R, L280I, E282D, T306K, V433N, V433R, I593E, I593W) into MMLV RTase to alter the enzyme's thermostability and activity parameters. These mutations enable the enzyme to maintain functionality at elevated temperatures while preserving cDNA synthesis efficiency, thus resolving the contradiction between handling structured RNAs and maintaining productivity
2Temperature
If AMV RTase is used for long RNA molecules, then heat stability improves, but RNA integrity and transcription fidelity decrease due to intrinsic RNase activity
Solution Approach 1:
The patent applies the extraction principle by removing the harmful RNase H domain from the RTase enzyme structure. This creates a RNase H-minus mutant that retains the polymerase activity and thermostability needed for handling long RNAs, while eliminating the RNA-degrading RNase H activity that compromises RNA integrity and transcription fidelity
3Productivity
If MMLV RTase mutants with reduced RNase H activity are used, then cDNA synthesis efficiency improves, but thermostability and ability to handle structured RNAs worsen
Solution Approach 1:
The patent applies the merging principle by combining two separate mutations: (1) RNase H-minus mutations that eliminate RNA degradation and improve cDNA synthesis efficiency, and (2) thermostability-enhancing mutations (Q68R, Q79R, L82Y, L99R, L280I, E282D, T306K, V433N, V433R, I593E, I593W) that improve heat stability. The combined mutant achieves both improved productivity and thermostability, resolving the contradiction between these two parameters
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The mutants exhibit increased RTase activity and thermostability, resulting in enhanced cDNA yield and fidelity, especially for RNA templates with complex secondary structures.
Implementation Method 1
RTase is a critical component of the reverse transcription polymerase chain reaction (RT-PCR) allowing the production of complementary DNA (cDNA) from RNA
Implementation Method 2
RNase H, a non-sequence-specific endonuclease enzyme that catalyzes cleavage of RNA in an RNA/DNA duplex
Data Source
AI summary
The disclosure provides Moloney murine leukemia virus (MMLV) reverse transcriptase (RTase) mutants. The disclosure as provides suitable amino acid positions in MMLV RTase for mutagenesis and methods and kits for using MMLV RTase mutants to synthesize cDNA from RNA templates.